Sutapa Ray

2.6k total citations
74 papers, 2.0k citations indexed

About

Sutapa Ray is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Sutapa Ray has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Organic Chemistry. Recurrent topics in Sutapa Ray's work include Protein Degradation and Inhibitors (11 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Glioma Diagnosis and Treatment (6 papers). Sutapa Ray is often cited by papers focused on Protein Degradation and Inhibitors (11 papers), Cytokine Signaling Pathways and Interactions (8 papers) and Glioma Diagnosis and Treatment (6 papers). Sutapa Ray collaborates with scholars based in United States, India and Denmark. Sutapa Ray's co-authors include Allan R. Brasier, Tieying Hou, István Boldogh, Chang Lee, Hemanta K. Majumder, Kishor K. Bhakat, Adrián Recinos, Dipakranjan Mal, Ronald G. Tilton and Hong Sun and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Sutapa Ray

65 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sutapa Ray United States 26 1.1k 419 360 238 185 74 2.0k
Yong Xia China 27 903 0.8× 568 1.4× 286 0.8× 199 0.8× 232 1.3× 77 2.0k
Zhongtao Zhang United States 26 1.4k 1.3× 426 1.0× 289 0.8× 119 0.5× 153 0.8× 36 2.1k
Katarzyna Piwocka Poland 29 1.4k 1.3× 370 0.9× 288 0.8× 105 0.4× 202 1.1× 80 2.4k
Jim Leisten United States 11 1.6k 1.5× 500 1.2× 554 1.5× 188 0.8× 377 2.0× 14 2.7k
Seung Bae Rho South Korea 28 1.6k 1.5× 409 1.0× 243 0.7× 157 0.7× 436 2.4× 83 2.3k
Jonathan Blay Canada 27 1.1k 1.0× 694 1.7× 631 1.8× 146 0.6× 225 1.2× 61 2.5k
Vanina A. Medina Argentina 22 979 0.9× 327 0.8× 640 1.8× 98 0.4× 206 1.1× 71 1.9k
Janet Dawson Switzerland 25 797 0.7× 276 0.7× 652 1.8× 116 0.5× 168 0.9× 52 2.1k
Sébastien Cagnol Canada 15 1.5k 1.4× 489 1.2× 308 0.9× 102 0.4× 305 1.6× 17 2.3k

Countries citing papers authored by Sutapa Ray

Since Specialization
Citations

This map shows the geographic impact of Sutapa Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sutapa Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sutapa Ray more than expected).

Fields of papers citing papers by Sutapa Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sutapa Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sutapa Ray. The network helps show where Sutapa Ray may publish in the future.

Co-authorship network of co-authors of Sutapa Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Sutapa Ray. A scholar is included among the top collaborators of Sutapa Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sutapa Ray. Sutapa Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alford, Susan, et al.. (2026). Early Alzheimer's diagnosis: U.S. primary care physicians and use of blood biomarkers. Alzheimer s & Dementia. 22(1). e70986–e70986.
2.
Coulter, Donald W., Yashpal S. Chhonker, Devendra Kumar, et al.. (2024). Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma. Journal of Experimental & Clinical Cancer Research. 43(1). 18–18. 4 indexed citations
3.
Ray, Sutapa, et al.. (2023). Deciphering the Role of Fatty Acid–Metabolizing CYP4F11 in Lung Cancer and Its Potential As a Drug Target. Drug Metabolism and Disposition. 52(2). 69–79. 8 indexed citations
4.
Akbar, Anum, Phillip J. Wilder, Nagendra K. Chaturvedi, et al.. (2023). STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo. Cancers. 15(8). 2239–2239. 5 indexed citations
5.
Ray, Lipika & Sutapa Ray. (2023). Enhanced Anticancer Activity of siRNA and Drug Codelivered by Anionic Biopolymer: Overcoming Electrostatic Repulsion. Nanomedicine. 18(11). 855–874. 1 indexed citations
6.
Kling, Matthew J., Varun Kesherwani, Nitish K. Mishra, et al.. (2022). A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma. Journal of Experimental & Clinical Cancer Research. 41(1). 321–321. 12 indexed citations
7.
Ray, Sutapa, et al.. (2022). Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(6). 321–332. 12 indexed citations
8.
Ray, Sutapa, Nagendra K. Chaturvedi, Kishor K. Bhakat, Angie Rizzino, & Sidharth Mahapatra. (2021). Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment. Diagnostics. 12(1). 61–61. 24 indexed citations
9.
Kling, Matthew J., Sutapa Ray, Kishore B. Challagundla, et al.. (2021). Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma. BMC Cancer. 21(1). 1061–1061. 12 indexed citations
10.
Roychoudhury, Shrabasti, Hannah L. Harris, Anum Akbar, et al.. (2021). Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation. Cancer Letters. 520. 201–212. 17 indexed citations
11.
Chaturvedi, Nagendra K., Matthew J. Kling, Varun Kesherwani, et al.. (2020). A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma. Molecular Cancer Therapeutics. 19(6). 1351–1362. 12 indexed citations
12.
Hoekman, John, Sutapa Ray, Sheena K. Aurora, & Stephen B. Shrewsbury. (2020). The Upper Nasal Space—A Novel Delivery Route Ideal for Central Nervous System Drugs. 16(1). 25–25. 17 indexed citations
13.
Roychoudhury, Shrabasti, Bhopal Mohapatra, Sutapa Ray, et al.. (2019). Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer. Molecular Cancer Therapeutics. 19(1). 258–269. 18 indexed citations
14.
Chaturvedi, Nagendra K., Sidharth Mahapatra, Varun Kesherwani, et al.. (2019). Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma. BMC Cancer. 19(1). 1056–1056. 25 indexed citations
15.
Ray, Sutapa, Victor Banerjee, Mickaël Blaise, et al.. (2014). Critical Role of Zinc Ion on E. coli Glutamyl-Queuosine-tRNAAsp Synthetase (Glu-Q-RS) Structure and Function. The Protein Journal. 33(2). 143–149. 5 indexed citations
16.
Ray, Sutapa, Xiaoxi Ju, Hong Sun, et al.. (2013). The IL-6 Trans-Signaling-STAT3 Pathway Mediates ECM and Cellular Proliferation in Fibroblasts from Hypertrophic Scar. Journal of Investigative Dermatology. 133(5). 1212–1220. 100 indexed citations
17.
Ray, Sutapa, Ying Lü, Scott H. Kaufmann, et al.. (2004). Genomic Mechanisms of p210BCR-ABL Signaling. Journal of Biological Chemistry. 279(34). 35604–35615. 44 indexed citations
18.
Anand, Monika, Jeffrey S. Rush, Sutapa Ray, et al.. (2001). Requirement of the Lec35 Gene for All Known Classes of Monosaccharide-P-Dolichol-dependent Glycosyltransferase Reactions in Mammals. Molecular Biology of the Cell. 12(2). 487–501. 74 indexed citations
19.
Kranz, Christian, Jonas Denecke, Mark A. Lehrman, et al.. (2001). A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). Journal of Clinical Investigation. 108(11). 1613–1619. 104 indexed citations
20.
Ray, Sutapa, Hemanta K. Majumder, Ajit K. Chakravarty, et al.. (1996). Amarogentin, a Naturally Occurring Secoiridoid Glycoside and a Newly Recognized Inhibitor of Topoisomerase I from Leishmania donovani. Journal of Natural Products. 59(1). 27–29. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong Xia Breakdown of academic impact, for papers by Zhongtao Zhang Breakdown of academic impact, for papers by Katarzyna Piwocka Breakdown of academic impact, for papers by Jim Leisten Breakdown of academic impact, for papers by Seung Bae Rho Breakdown of academic impact, for papers by Jonathan Blay Breakdown of academic impact, for papers by Vanina A. Medina Breakdown of academic impact, for papers by Janet Dawson Breakdown of academic impact, for papers by Sébastien Cagnol
Rankless by CCL
2026